Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26740 | 202 | 25.0 | 28% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ALLERGEN FRAGMENTS | Author keyword | 1 | 50% | 0% | 1 |
| 2 | AMPLIFICATION FREE | Author keyword | 1 | 50% | 0% | 1 |
| 3 | H2 GENOTYPE | Author keyword | 1 | 50% | 0% | 1 |
| 4 | TOXICOGEN PROJECT | Address | 1 | 50% | 0% | 1 |
| 5 | INTRANASAL SENSITIZATION | Author keyword | 0 | 33% | 0% | 1 |
| 6 | POLY ALPHA AMINO ACIDS | Author keyword | 0 | 33% | 0% | 1 |
| 7 | ALLERGY IMMUNE P SYST | Address | 0 | 25% | 0% | 1 |
| 8 | BIACORE 3000 | Author keyword | 0 | 25% | 0% | 1 |
| 9 | PEPTIDE ANTIBODY INTERACTION | Author keyword | 0 | 25% | 0% | 1 |
| 10 | RD POLICY TEAM | Address | 0 | 25% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ALLERGEN FRAGMENTS | 1 | 50% | 0% | 1 | Search ALLERGEN+FRAGMENTS | Search ALLERGEN+FRAGMENTS |
| 2 | AMPLIFICATION FREE | 1 | 50% | 0% | 1 | Search AMPLIFICATION+FREE | Search AMPLIFICATION+FREE |
| 3 | H2 GENOTYPE | 1 | 50% | 0% | 1 | Search H2+GENOTYPE | Search H2+GENOTYPE |
| 4 | INTRANASAL SENSITIZATION | 0 | 33% | 0% | 1 | Search INTRANASAL+SENSITIZATION | Search INTRANASAL+SENSITIZATION |
| 5 | POLY ALPHA AMINO ACIDS | 0 | 33% | 0% | 1 | Search POLY+ALPHA+AMINO+ACIDS | Search POLY+ALPHA+AMINO+ACIDS |
| 6 | BIACORE 3000 | 0 | 25% | 0% | 1 | Search BIACORE+3000 | Search BIACORE+3000 |
| 7 | PEPTIDE ANTIBODY INTERACTION | 0 | 25% | 0% | 1 | Search PEPTIDE+ANTIBODY+INTERACTION | Search PEPTIDE+ANTIBODY+INTERACTION |
| 8 | 6 AMINO PENICILLANIC ACID | 0 | 20% | 0% | 1 | Search 6+AMINO+PENICILLANIC+ACID | Search 6+AMINO+PENICILLANIC+ACID |
| 9 | BETA LACTAM DRUGS | 0 | 20% | 0% | 1 | Search BETA+LACTAM+DRUGS | Search BETA+LACTAM+DRUGS |
| 10 | COUPLING CHEMISTRY | 0 | 20% | 0% | 1 | Search COUPLING+CHEMISTRY | Search COUPLING+CHEMISTRY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTI ALLERGIC DRUGS | 1 | 50% | 0% | 1 |
| 2 | IGE DETERMINATION | 1 | 50% | 0% | 1 |
| 3 | PULLULAN CONJUGATE | 1 | 50% | 0% | 1 |
| 4 | SUBSTITUTED POLYALPHA AMINO ACIDS | 1 | 50% | 0% | 1 |
| 5 | ANAPHYLAXIS SRS A | 0 | 17% | 0% | 1 |
| 6 | PARAMAGNETIC NANOPARTICLES | 0 | 17% | 0% | 1 |
| 7 | PEPTIC FRAGMENTS | 0 | 17% | 0% | 1 |
| 8 | POLYMETHYLSILSESQUIOXANES | 0 | 10% | 0% | 1 |
| 9 | 10 YEAR PROGNOSIS | 0 | 100% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| SUPPRESSION OF IGE ANTIBODY-RESPONSES WITH TOLEROGENIC CONJUGATES OF ALLERGENS AND HAPTENS | 1982 | 46 | 20 | 50% |
| THE EFFECT OF DRUGS ON IGE ANTIBODIES PRODUCTION | 1986 | 0 | 9 | 78% |
| Effectiveness of Pharmacopuncture for Asthma: A Systematic Review and Meta-Analysis | 2011 | 0 | 7 | 14% |
| INFLUENCE OF THE STRUCTURO-CHEMICAL PECULIARITIES OF WATER-SOLUBLE POLYELECTROLYTE COMPLEXES OF OVALBUMIN ON THEIR IMMUNOLOGICAL PROPERTIES | 1990 | 2 | 7 | 29% |
| RELEVANCE OF ANIMAL-MODELS FOR STUDIES OF IMMUNE REGULATION OF ATOPIC ALLERGY | 1984 | 11 | 48 | 25% |
| THE MAST-CELL SYSTEM IN REPRODUCTIVE TOXICOLOGY | 1990 | 0 | 18 | 22% |
| ORIGIN OF TISSUE BASOPHILS AND BASOPHILIC BLOOD GRANULOCYTES | 1983 | 0 | 3 | 67% |
| NOVEL APPROACHES IN IMMUNOTHERAPY | 1994 | 7 | 84 | 4% |
| REGULATION OF THE IGE ANTIBODY-RESPONSE - MOUSE IGE | 1982 | 13 | 21 | 19% |
| Peptide therapy for treatment of allergic diseases | 1996 | 10 | 41 | 2% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TOXICOGEN PROJECT | 1 | 50% | 0.5% | 1 |
| 2 | ALLERGY IMMUNE P SYST | 0 | 25% | 0.5% | 1 |
| 3 | RD POLICY TEAM | 0 | 25% | 0.5% | 1 |
| 4 | WORLD PREMIER | 0 | 13% | 0.5% | 1 |
| 5 | FAMILY HOPE | 0 | 100% | 0.5% | 1 |
| 6 | INSELSPITAL CLIN IMMUNOL | 0 | 100% | 0.5% | 1 |
| 7 | PTHYSIAT PULMONOL | 0 | 100% | 0.5% | 1 |
| 8 | UPR 9021 CNRS IMMUNOL CHIM THER EUT | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000145575 | HYBROTEC//ASTER YOMENA//ENERGY TRANSFER PROBE |
| 2 | 0.0000140195 | CD23//SOLUBLE CD23//LOW AFFINITY IGE RECEPTOR |
| 3 | 0.0000115646 | CX 659S//EARLY TYPE HYPERSENSITIVITY//BIPHASIC CUTANEOUS REACTION |
| 4 | 0.0000089929 | ANAT 4120//LUNG COMPARTMENTS//PULM CRIT CARE MED SECT 111G |
| 5 | 0.0000086855 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//TABM//GLYCOSYLATION INHIBITING FACTOR |
| 6 | 0.0000085888 | SUBLINGUAL IMMUNOTHERAPY//SUBCUTANEOUS IMMUNOTHERAPY//SPECIFIC IMMUNOTHERAPY |
| 7 | 0.0000083271 | AUTOANTI IGE//IGG ANTI IGE//ANTI IGE AUTOANTIBODY |
| 8 | 0.0000075362 | ORAL TOLERANCE//EPICUTANEOUS IMMUNIZATION//MUCOSAL TOLERANCE |
| 9 | 0.0000075335 | BENZHYDRYLAMINE RESIN//TOAC//CHIRAL NITROXIDES |
| 10 | 0.0000075152 | PRINCESS ELISABETH CHILDRENS HOSP//ASTHMA ALLERG DIS IMMUNE DISORDERS//EOSINOPHILIC GASTROENTEROCOLITIS |